Cardiology Perspective

 
 

  • Can GLP-1s Reduce Alzheimer’s Disease Risk? Caroline Messer, MD, shares how she prescribed a GLP-1 receptor agonist to a patient as possible low-risk prophylaxis against Alzheimer’s disease.
  • Making Sense of Mixed Messages on Drinking   Medscape’s Neha Pathak, MD, and George Koob, PhD, Director of the National Institute on Alcohol Abuse and Alcoholism, break down the latest guidance on alcohol intake.
  • HBP: What Happened in the 1930s Should Stay There   Christopher Labos, MD CM, MSc, makes sense of nearly 100 years of blood pressure recommendations.
  • Benefits of Playing Drums: Physical, Mental, and Social   Professor David Kerr discusses the benefits of drumming.
  • Medscape 2050: The Future of Medicine As Medscape marks its 30th anniversary, we are collaborating with physicians, scientists, and futurists to envision the future of medicine in the year 2050.
  • Novel Insights in Thrombotic Disorders From ASH 2024   Rilzabrutinib and eltrombopag in immune thrombocytopenia, and the place of oral direct anticoagulation in venous thromboembolism, are among the novel insights in thrombotic disorders from ASH 2024.
  • Preventing DKA in Patients With T1D on SGLT2 Inhibitors   Dr Anne Peters discusses how to safely prescribe SGLT2 inhibitors in patients with type 1 diabetes to prevent diabetic ketoacidosis.
  • Dec 20 2024 This Week in Cardiology   Listener feedback, multiple studies in AF ablation, a DANISH trial substudy of ICDs in NICM, and more data on eye complications of GLP-1 agonists are the topics John Mandrola, MD, covers in this week’s podcast.
  • Diener’s Top 12 Neurology Stories in 2024   Prof Christoph Diener picks his top neurology publications in 2024 covering Alzheimer’s, stroke, Parkinson’s, migraine, glioblastoma, long COVID, and the GLP-1 drugs.
  • “I Had No Words”: The Patient Gifts Doctors Never Forget   These doctors were surprised and moved by very personal gifts given to them by grateful patients. Enjoy some good vibes this holiday season.
  • Episode 8: Triglycerides, HDL, and Cardiorenal Metabolic Syndrome   Join Drs Nihar Desai and Pam Taub as they discuss the nuances involved in understanding and managing triglycerides and HDL for cardiorenal metabolic syndrome.
  • Cardiac Sarcoidosis: Diagnostic Tips for Clinicians   Dr Farooq Sheikh discusses the key aspects to making a diagnosis of cardiac sarcoidosis.
  • Injectable Weight Loss Drugs and Environmental Issues   Ethicist Art Caplan discusses ethical and environmental issues related to the use of injectable drugs for weight loss.
  • Dec 13 2024 This Week in Cardiology   US doc's pay, the ticagrelor controversy and new RCTs, clopidogrel beats ASA, holding antiplatelets for non-cardiac surgery, and Prof Cleland and ASA dogma are the topics John Mandrola, MD, covers this week.
  • AHA 2024 Drugs to Target Lp(a): What’s Coming   Cardiologists Michelle O’Donoghue and Stephen Nicholls discuss the status of drugs in development that target lipoprotein (a) including recent data from the American Heart Association meeting.
  • How to Avoid Freaking Out About Kidney Function   According to kidney expert Dr Joel Topf, albuminuria is a better prognostic indicator of kidney function than eGFR.
  • Gout: Diagnosis and Management in Primary Care   Physicians must consider questions related to medications, lifestyle advice, and long-term follow-up for their patients with gout.
  • Good and Bad: Medscape Nurse Career Satisfaction Report 2024 Most nurses say they are happy with their career choice and would make it again. They also list their biggest job rewards and headaches, and recount experiences with abuse.
  • Mandrola’s Top 10 Stories in 2024 Cardiologist John Mandrola reviews his top 10 stories in 2024 covering beta-blockers, GLP-1s, finerenone, Impella, pulsed field ablation, tricuspid intervention, and a potential renaming of STEMI.
  • Medscape Female Physician Career Tracks Report 2024 From mentorship to leadership, female physicians navigate unique challenges as they build thriving medical careers.